Wojciech Pietrus
12 Smętna Str
Krakow, MA 31324, Poland
Krakow, MA 31324, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
NMR-AI: An Open Platform for NMR-Enhanced Molecular Representations and Physicochemical Property Prediction.
Journal: Journal of chemical information and modeling
Published: July 16, 2026
Identification of pyrrolo[2,3-d]pyrimidine-based dual MERTK and FLT3 inhibitor: Hit-to-lead, machine learning, modeling, synthesis, and biological evaluation.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: October 31, 2025
From NMR to AI: Fusing 1H and 13C Representations for Enhanced QSPR Modeling.
Journal: Journal of chemical information and modeling
Published: September 17, 2025
Fluorine-induced perturbations in hydrogen bond networks: Insights from FT-IR, Raman, and AIMD simulations.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: July 26, 2025
From NMR to AI: Do We Need 1H NMR Experimental Spectra to Obtain High-Quality logD Prediction Models?
Journal: Journal of chemical information and modeling
Published: March 05, 2025
Histamine H3 receptor blockade alleviates neuropathic pain through the regulation of glial cells activation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 18, 2024
5-HT6 receptor neutral antagonists protect astrocytes: A lesson from 2-phenylpyrrole derivatives.
Journal: European journal of medicinal chemistry
Published: April 26, 2024
From NMR to AI: Designing a Novel Chemical Representation to Enhance Machine Learning Predictions of Physicochemical Properties.
Journal: Journal of chemical information and modeling
Published: March 26, 2024
Superiority of the Triple-Acting 5-HT6R/5-HT3R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT6R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats.
Journal: Journal of medicinal chemistry
Published: October 05, 2023
Preclinical characterization of CPL304110 as a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3 for gastric, bladder, and squamous cell lung cancer.
Journal: Frontiers in oncology
Published: September 13, 2023
Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain.
Journal: Journal of medicinal chemistry
Published: July 07, 2023
Last Updated: 09/26/2026